BCL-2 (b-cell lymphoma 2) inhibitors market size to increase by USD 1,657.08 million between 2022 and 2027; Growing approval of combination therapy identified as key trend - Technavio

Source :: Plus Company Updates. March 11, 2023
Publication Year :: 2023
Abstract: NEW YORK: Technavio has issued the following news release: The BCL-2 (b-cell lymphoma 2) inhibitors market size is forecast to grow by USD 1,657.08 million between 2022 and 2027, and [...]

Subjects :: Merck & Company Inc. -- Forecasts and trends
Amgen Inc. -- Forecasts and trends
AbbVie Inc. -- Forecasts and trends
Bristol-Myers Squibb Co. -- Forecasts and trends
Novartis AG -- Forecasts and trends
Seagen Inc. -- Forecasts and trends
Techne Corp. -- Forecasts and trends
AstraZeneca PLC -- Forecasts and trends
F. Hoffmann-La Roche Ltd. -- Forecasts and trends
Medical test kit industry -- Forecasts and trends -- Market size
Biotechnology industry -- Forecasts and trends -- Market size
Lymphomas -- Forecasts and trends
Medical equipment and supplies industry -- Forecasts and trends -- Market size
Pharmaceutical industry -- Forecasts and trends -- Market size
Market trend/market analysis
General interest
News, opinion and commentary

Tools